Teva swallows Allergan Generic for $40.5 billion
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
Teva buys Allergan's generic drug unit for $40.5B
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva to buy Allergan Generics for $40.5B
Teva deal lets us double down on brands: Allergan CEO
Israel's Teva to buy Allergan for $40.5bn
Teva, Allergan enter into $58m opioid settlement with San Francisco
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Allergan becomes largest shareholder in Teva - Globes
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva, Allergan Tweak Acquisition Agreement - WSJ
Teva nears deal for Allergan's generic drugs unit | Mint
Teva's Multibillion-Dollar Purchase of Allergan Approved
Teva divesting $1 billion in assets to clear Allergan deal
Teva, Allergan Get FTC Approval for Generics Purchase - WSJ
Teva stands behind Allergan price - Globes
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | The Seattle Times
Teva And Allergan Acquisition: Why Are Pharmaceutical Companies Making So Many Deals Right Now?
California lawsuit leads to Allergan, Teva receiving $54 million fine | Fox Business
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva Springs for $40.5B Allergan Generics Acquisition Instead of Mylan Bid - YouTube
Teva drops Mylan deal in favour of Allergan
